Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Business Update

13 Dec 2017 07:00

RNS Number : 1524Z
Alexander Mining PLC
13 December 2017
 

13 December 2017

Alexander Mining plc

("Alexander" or the "Company")

Business Update

 

Alexander is pleased to provide an update on its business development activities.

 

Australia - Accudo agreement

 

The Company has received an update from Accudo Metals Pty Ltd. ("Accudo") regarding its agreement with the owners of the copper tenements and assets in Australia ("the Project"). The Project is being assessed in accordance with the technology licence agreement with Alexander for the potential use of the Company's AmmLeach® technology.

Accudo's planned technical work is to progress from the first stage test work and complete a definitive feasibility study ("DFS") with a view to producing a bankable feasibility study ("BFS") if the DFS is positive. Work to date has demonstrated the successful extraction of copper under a range of AmmLeach® conditions and with recoveries (65%-80% unoptimised) comparable to acid leaching, albeit the latter processing method is uneconomic due to excessive sulphuric acid consumption.

 

To support the DFS, Accudo has selected the members of the feasibility study team, which includes hydrometallurgical and engineering, geology and mining, environmental, legal and corporate and financial advisors. In addition, significant size bulk samples of approximately 20 tonnes of ore and about 140 kg of quartered diamond drilling core have been sourced and transported to Perth, Western Australia for appropriate metallurgical and mineral processing test work.

 

Accudo has advised the Company that it is sufficiently encouraged by the technical work undertaken to date and its preliminary economic model, that it is currently seeking expressions of interest from strategic, industry and/or financial investors for funding to effect the acquisition of the Project assets. Its earlier intention was to decide on whether to acquire the Project once the DFS was completed. In the interim, the DFS work has been put on hold pending this further funding for the acquisition of the Project, completion of the DFS work and, if favourable, the commitment to complete a BFS.

 

Accudo has indicated that expressions of interest have been encouraging and several organisations are currently accessing the Project data room. 

 

HyperLeach®

 

The Company is investigating potential low-grade nickel/cobalt and copper sulphide leaching opportunities to advance the potential commercial adoption of its HyperLeach® intellectual property. The recent grant of the HyperLeach® patent in the US is supportive of this.

 

Lithium - research and development joint venture

 

Work on the lithium ore leaching joint venture between the Company and Dr Nicholas Welham is proceeding and, although there has been some time slippage due to the availability of laboratory facilities, the first results are expected soon.

 

Zambia

 

Further to the signing of an introducer's agreement with Duard Capital Ltd. ("Duard") announced on 16 August 2017, the Company has been working closely with Duard to investigate several opportunities. The focus is on copper and cobalt production opportunities, including from historic slag/tailings heaps, and has been supported by a recent visit to Zambia by the Company.

 

Large numbers of Zambians depend on the income from the small scale artisanal mining of copper ore outcrops. The ore is sold at a marked discount to contained metal value to a few processing plants. The Zambian government has voiced its desire to see an improved return to such miners but with limited success.

 

The biggest challenge is to overcome the cost of transporting small quantities of ore over long distances. Duard and Alexander believe that there is an opportunity for the AmmLeach® technology to address this problem by establishing several small-scale plants serving such copper mining regions.

 

Outside of the Duard agreement, Alexander remains in discussions with existing major producers around the potential for the use of its patented technologies to enhance both current production and expansion opportunities they have within their existing resource and reserve asset base.

 

Turkey

 

The Company continues to investigate, supported by several recent visits, several specific opportunities in Turkey for its technology on suitable copper and/or zinc projects.

 

Mongolia

 

The Company's agent, Dr. Jadambaa Temuujin, has been busy generating contacts with encouraging interest being shown.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

ENDS

For further information, please contact:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

 

Alan Clegg

Non-Executive Chairman

Mobile: +90 543 533 0665

 

 

Alexander Mining plc

Tel: +44 (0) 20 7078 9566

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

 

Northland Capital Partners Limited 

Matthew Johnson / Gerry Beaney

(Corporate Finance)

John Howes

(Corporate Broking)

Tel: +44 (0) 20 3861 6625

 

 

Turner Pope Investments (TPI) Ltd

Andy Thacker

Tel: +44 (0) 20 3621 4120

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDVLLFFDLFFFBK
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.